weight loss injections tirzepatide side effects Chicago What Are the Side Effects

COVID-19 is caused by a virus that can lead to serious illness, especially in people who have certain health conditions or weakened immune systems

CagriSema submitted for FDA approval in December 2025 with expected approval in Q4 2026 or Q1 2027, meaning launch around mid-2027

A smaller subset experiences persistent but manageable diarrhea that doesn't interfere with daily function

Injectable GHK-Cu has demonstrated systemic effects in animal models -- lung fibrosis protection, connective tissue remodeling, neuroprotection -- but translating those findings to human subcutaneous injection protocols remains speculative